Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN - Archive ouverte HAL Access content directly
Journal Articles Journal of the American Society of Nephrology Year : 2015

Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN

(1) , (2, 1) , (1) , (3, 1) , (1) , (1) , (1) , (1) , (4) , (1) , (1) , (1, 5) , (5, 1) , (6) , (1)
1
2
3
4
5
6

Abstract

Necrotizing and crescentic rapidly progressive GN (RPGN) is a life-threatening syndrome characterized by a rapid loss of renal function. Evidence suggests that podocyte expression of the transcription factor peroxisome proliferator-activated receptor γ (PPARγ) may prevent podocyte injury, but the function of glomerular PPARγ in acute, severe inflammatory GN is unknown. Here, we observed marked loss of PPARγ abundance and transcriptional activity in glomerular podocytes in experimental RPGN. Blunted expression of PPARγ in podocyte nuclei was also found in kidneys from patients diagnosed with crescentic GN. Podocyte-specific Pparγ gene targeting accentuated glomerular damage, with increased urinary loss of albumin and severe kidney failure. Furthermore, a PPARγ gain-of-function approach achieved by systemic administration of thiazolidinedione (TZD) failed to prevent severe RPGN in mice with podocyte-specific Pparγ gene deficiency. In nuclear factor erythroid 2-related factor 2 (NRF2)-deficient mice, loss of podocyte PPARγ was observed at baseline. NRF2 deficiency markedly aggravated the course of RPGN, an effect that was partially prevented by TZD administration. Furthermore, delayed administration of TZD, initiated after the onset of RPGN, still alleviated the severity of experimental RPGN. These findings establish a requirement for the NRF2-PPARγ cascade in podocytes, and we suggest that these transcription factors have a role in augmenting the tolerance of glomeruli to severe immune-complex mediated injury. The NRF2-PPARγ pathway may be a therapeutic target for RPGN.
Fichier principal
Vignette du fichier
172.full.pdf (6.26 Mo) Télécharger le fichier
Loading...

Dates and versions

inserm-03788642 , version 1 (26-09-2022)

Identifiers

Cite

Carole Henique, Guillaume Bollee, Olivia Lenoir, Neeraj Dhaun, Marine Camus, et al.. Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN. Journal of the American Society of Nephrology, 2015, 27 (1), pp.172-188. ⟨10.1681/ASN.2014111080⟩. ⟨inserm-03788642⟩
15 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More